{"DataElement":{"publicId":"3099344","version":"1","preferredName":"Patient Melanoma American Joint Committee on Cancer Staging Eligibility Determination Type","preferredDefinition":"the type as related to patient's stage (or extent of cancer within the body) of a malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin for determining eligibility for medical care in study.","longName":"3099340v1.0:3099341v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3099340","version":"1","preferredName":"Patient Melanoma American Joint Committee on Cancer Staging Eligibility Determination","preferredDefinition":"information related to patient's stage (or extent of cancer within the body) of a malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin for determining eligibility for medical care in study.","longName":"2233604v1.0:3099338v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3099338","version":"1","preferredName":"Melanoma American Joint Committee on Cancer Staging Eligibility Determination","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C3224:C39315:C15608:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Staging","conceptCode":"C15608","definition":"The process of defining at what point in the natural history of a malignant disease a patient is when a diagnosis is made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"876C7CA8-B701-F286-E040-BB89AD437B88","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ONEDATA","dateModified":"2010-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"876C7CA8-B712-F286-E040-BB89AD437B88","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3099341","version":"1","preferredName":"Melanoma American Joint Committee on Cancer Staging Eligibility Determination Type","preferredDefinition":"a subdivision of melanoma staging based on American Joint Committee on Cancer staging for eligibility determination.","longName":"3099341v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1c","valueDescription":"M1c","ValueMeaning":{"publicId":"2647709","version":"1","preferredName":"M1c","longName":"2647709","preferredDefinition":"M1c","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"324313E1-96D5-709D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-06","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"876CD401-ACA8-1AA4-E040-BB89AD434C26","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ONEDATA","dateModified":"2010-05-25","deletedIndicator":"No"},{"value":"M1a/1b","valueDescription":"M1a/1b","ValueMeaning":{"publicId":"3099342","version":"1","preferredName":"M1a/1b","longName":"3099342","preferredDefinition":"M1a/1b","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"876C7CA8-B73A-F286-E040-BB89AD437B88","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"876C7CA8-B753-F286-E040-BB89AD437B88","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ONEDATA","dateModified":"2010-05-25","deletedIndicator":"No"},{"value":"Unresectable","valueDescription":"Unresectable","ValueMeaning":{"publicId":"2964842","version":"1","preferredName":"Unresectable","longName":"2964842","preferredDefinition":"Unable to be removed with surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unresectable","conceptCode":"C14151","definition":"Not capable of being removed by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A02CEF7-C9D2-C96C-E040-BB89AD430150","latestVersionIndicator":"Yes","beginDate":"2009-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"876C7CA8-B75D-F286-E040-BB89AD437B88","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ONEDATA","dateModified":"2010-05-25","deletedIndicator":"No"},{"value":"M1b","valueDescription":"M1b Stage Finding","ValueMeaning":{"publicId":"3603645","version":"1","preferredName":"M1b Stage Finding","longName":"3603645","preferredDefinition":"A TNM finding indicating the spread of cancer to distant anatomic sites.  The definition of M1b TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer it refers to metastases in more than one organ/site or the peritoneum; for prostate cancer it refers to metastasis to bone(s); for bone cancer it refers to metastasis to distant sites other than lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"M1b TNM Finding","conceptCode":"C48702","definition":"A TNM finding indicating the spread of cancer to distant anatomic sites.  The definition of M1b TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer it refers to metastases in more than one organ/site or the peritoneum; for prostate cancer it refers to metastasis to bone(s); for bone cancer it refers to metastasis to distant sites other than lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB2E55F4-033A-F3A6-E040-BB89AD4318A2","latestVersionIndicator":"Yes","beginDate":"2012-10-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB2E55F4-0353-F3A6-E040-BB89AD4318A2","beginDate":"2012-10-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-03","modifiedBy":"ONEDATA","dateModified":"2012-10-03","deletedIndicator":"No"},{"value":"III/M1a","valueDescription":"Stage III M1a Stage Finding","ValueMeaning":{"publicId":"3603646","version":"1","preferredName":"Stage III M1a Stage Finding","longName":"3603646","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.: A TNM finding indicating the spread of cancer to distant anatomic sites.  The definition of M1a TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer it refers to metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node); for prostate cancer it refers to metastasis to non-regional lymph node(s); for bone cancer it refers to metastasis to the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III","conceptCode":"C27970","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M1a TNM Finding","conceptCode":"C48701","definition":"A TNM finding indicating the spread of cancer to distant anatomic sites.  The definition of M1a TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer it refers to metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node); for prostate cancer it refers to metastasis to non-regional lymph node(s); for bone cancer it refers to metastasis to the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB2E55F4-0360-F3A6-E040-BB89AD4318A2","latestVersionIndicator":"Yes","beginDate":"2012-10-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB2E55F4-0379-F3A6-E040-BB89AD4318A2","beginDate":"2012-10-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-03","modifiedBy":"ONEDATA","dateModified":"2012-10-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"876C7CA8-B724-F286-E040-BB89AD437B88","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ALAIS","dateModified":"2012-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"AJCC Stage","type":"Preferred Question Text","description":"AJCC Stage","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Stage","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"876C7CA8-B768-F286-E040-BB89AD437B88","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ALAIS","dateModified":"2012-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}